Skip to main content

Health

Philips Reinforces Strategic Leadership and Governance Stability with Unanimous AGM 2025 Shareholder Approval

Submitted by J. Mikhail on

SHERIDAN, WYOMING – May 11, 2025 – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, has announced unanimous shareholder approval of all proposals presented at its 2025 Annual General Meeting (AGM), reinforcing the company’s commitment to strong corporate governance, strategic continuity, and long-term value creation.

KaVo Launches Limited-Time Promotion on ELECTROmatic Premium Motor System to Boost Dental Practice Efficiency

Submitted by J. Mikhail on

SHERIDAN, WYOMING – May 11, 2025 – KaVo, a global leader in dental equipment innovation, is spotlighting its ELECTROmatic Premium motor system with a flash promotion running through May 30, 2025—offering dental professionals a timely opportunity to elevate their operatory performance with one of the most advanced electric handpiece systems on the market.

Dentsply Sirona and AADOCR Celebrate Student Innovation with 2025 SCADA Awards

Submitted by J. Mikhail on

SHERIDAN, WYOMING – May 11, 2025 – Dentsply Sirona, in partnership with the American Association for Dental, Oral and Craniofacial Research (AADOCR), has officially announced the winners of the 2025 Student Competition for Advancing Dental Research and its Application (SCADA) Awards. Unveiled during the Opening Ceremonies of the 54th AADOCR Annual Meeting in New York, the awards spotlight student-led research poised to shape the future of oral healthcare innovation.

Highlighting Student Research Excellence in Dental Science

LivaNova Reports First-Quarter 2025 Results; Updates 2025 Guidance

Submitted by fairsonline´s … on

SHERIDAN, WYOMING – May 9, 2025 – LivaNova PLC, a global leader in medical technology, announced strong first-quarter 2025 results today, demonstrating continued growth and operational efficiency. The company reported high single-digit revenue growth, including double-digit organic revenue increases, as well as expanding operating margins. LivaNova also raised its full-year 2025 revenue guidance, taking into account the impact of the SNIA environmental liability and current tariffs.

LivaNova Announces 12-month Data from OSPREY Clinical Study for Moderate to Severe Obstructive Sleep Apnea, Demonstrating Strong Response and Durability of Therapy

Submitted by fairsonline´s … on

SHERIDAN, WYOMING – May 9, 2025 – LivaNova PLC, a leading global medical technology company, has announced 12-month top-line data from its OSPREY clinical trial. The study demonstrates promising results for the aura6000™ System, an investigational device designed to treat moderate to severe obstructive sleep apnea (OSA). The data highlights sustained improvements in key health metrics, positioning the aura6000™ as a potential breakthrough in OSA management.

Globus Medical Reports First Quarter 2025 Results, Reflecting Strategic Investments and Operational Growth

Submitted by fairsonline´s … on

SHERIDAN, WYOMING – May 09, 2025 – Globus Medical, Inc. (NYSE: GMED), a leading provider of musculoskeletal solutions, has announced its financial results for the first quarter of 2025. The company reported worldwide net sales of $598.1 million, reflecting a 1.4% decrease year-over-year, primarily driven by a slowdown in Enabling Technology deal closures and temporary supply chain disruptions. Despite these challenges, Globus Medical saw notable growth in its core U.S. spine business and remains optimistic about its future prospects.

Globus Medical Reports First Quarter 2025 Results, Announces Strategic Growth Plans

Submitted by fairsonline´s … on

SHERIDAN, WYOMING – May 9, 2025 – Globus Medical, Inc. (NYSE: GMED), a prominent player in the musculoskeletal solutions industry, has reported its financial results for the first quarter of 2025. Despite a slight dip in global net sales, the company remains confident in its ability to drive long-term growth and innovation. The results reflect challenges faced in certain areas, including slower deal closures in Enabling Technology, but also showcase the company’s strong positioning in the U.S. spine business.

Enovis Announces Appointment of Damien McDonald as Chief Executive Officer

Submitted by fairsonline´s … on

SHERIDAN, WYOMING – May 9, 2025 – Enovis Corporation (NYSE: ENOV), a global leader in medical technology, has appointed Damien McDonald as its new Chief Executive Officer, effective May 12, 2025. McDonald, who will also join the Enovis Board of Directors following the Company’s 2025 Annual Meeting of Stockholders, succeeds Matt Trerotola, who has announced his retirement. This strategic leadership transition positions Enovis for continued growth and innovation in the medical technology sector.

Move For Mobility 2025 Launches Today – Let’s Get Moving!

Submitted by fairsonline´s … on

SHERIDAN, WYOMING – May 8, 2025 – Invacare is proud to announce the launch of its global fundraiser, Move For Mobility 2025, which aims to provide life-changing wheelchairs to individuals in need around the world. The initiative brings together Invacare employees, ambassadors, clients, and partners in a worldwide effort to raise awareness and funds for the Free Wheelchair Mission, an organization committed to delivering wheelchairs at no cost to people with disabilities in remote communities.

Mölnlycke Health Care Champions Standardization of Wound Dressing Testing to Boost Patient Outcomes

Submitted by fairsonline´s … on

SHERIDAN, WYOMING – May 8, 2025 – Mölnlycke Health Care has reiterated its unwavering support for the Wound Care Collaborative Community (WCCC) initiative, which seeks to develop a standardized pre-clinical testing framework for wound dressings. The collaboration aims to drive improvements in patient care by ensuring more consistent and clinically relevant product evaluations across the wound care industry.